2:
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.
PMID: 17049139 [PubMed - indexed for MEDLINE]
Related Articles
16:
Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis.
Laivoranta-Nyman S, Möttönen T, Hannonen P, Korpela M, Kautiainen H, Leirisalo-Repo M, Julkunen H, Luukkainen R, Hakala M, Vuori K, Laine AP, Toivanen A, Ilonen J; FIN-RACo Trial Group.
Clin Exp Rheumatol. 2006 Nov-Dec;24(6):636-42.
PMID: 17207378 [PubMed - indexed for MEDLINE]
Related Articles